Cancer Research includes companies working on scientific research aimed at understanding the causes, prevention, diagnosis, treatment, and potential cures for cancer. It includes many disciplines, from biology and genetics, to clinical trials and drug development, with the ultimate goal of improving cancer care and outcomes. Cancer research companies are developing life-saving treatments and diagnostics for a growing market in high demand. These companies constantly innovate, have a global reach, and form important strategic partnerships, which makes them appealing to investors looking for profits and supporting health progress.
Looking At Merck & Co's Recent Unusual Options Activity
Deep-pocketed investors have adopted a bullish approach towards Merck & Co (NYSE:MRK), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled t
Blue Goes Big: Blueprint Prep's AI MCAT Tutor Now Covers Entire MCAT Exam and Makes MCAT Prep More Efficient
LOS ANGELES, March 28, 2024 /PRNewswire/ -- Building on its commitment to leveraging advanced technology for enhanced learning experiences, Blueprint Prep is proud to announce a significant expansion
10 Health Care Stocks With Whale Alerts In Today's Session
This whale alert can help traders discover the next big trading opportunities.Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scan
Form 144 | Exact Sciences(EXAS.US) Officer Proposes to Sell 140K in Common Stocks
SEC FILLINGS DISCLOSED/ Mar 28, $Exact Sciences(EXAS.US)$ Officer Condella Sarah intends to sell 2,000 shares of its common stock on Mar 28, with a total market value of approximately $140K. Condell
Cancer Focused Micro-Cap Xilio Therapeutics Stock Doubles In One Session - Here's Why
Xilio Therapeutics Inc (NASDAQ:XLO) shares are surging as the company announced an exclusive license agreement with Gilead Sciences Inc (NASDAQ:GILD) to develop and commercialize Xilio's Phase 1 tumor
Astellas & Pfizer's SBLA For Enfortumab Vedotin With Keytruda Gets Approval In China